1.6K
Articles
47.8K
Citations
3.2
avg. Impact Factor
92
h-index

Most Cited Articles of Department of Oncology in 2013

TitleJournalYearCitations
Adjuvant treatments for resected pancreatic adenocarcinoma: a systematic review and network meta-analysisLancet Oncology, The2013168
Mcl-1-dependent activation of Beclin 1 mediates autophagic cell death induced by sorafenib and SC-59 in hepatocellular carcinoma cellsCell Death and Disease2013145
Activating oxidative phosphorylation by a pyruvate dehydrogenase kinase inhibitor overcomes sorafenib resistance of hepatocellular carcinomaBritish Journal of Cancer2013137
A multinational phase 2 study of nanoliposomal irinotecan sucrosofate (PEP02, MM-398) for patients with gemcitabine-refractory metastatic pancreatic cancerBritish Journal of Cancer2013128
MiR-520h-mediated FOXC2 regulation is critical for inhibition of lung cancer progression by resveratrolOncogene201398
Hepatitis B virus reactivation in B-cell lymphoma patients treated with rituximab: analysis from the Asia Lymphoma Study GroupEuropean Journal of Cancer201389
Diarrhea associated with afatinib: an oral ErbB family blockerExpert Review of Anticancer Therapy201373
Distant metastasis in triple-negative breast cancerNeoplasma201369
Targeting colorectal cancer cells with single-walled carbon nanotubes conjugated to anticancer agent SN-38 and EGFR antibodyBiomaterials201368
Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapyCancer201365
MEK inhibitors reverse resistance in epidermal growth factor receptor mutation lung cancer cells with acquired resistance to gefitinibMolecular Oncology201361
Actin depolymerization under force is governed by lysine 113:glutamic acid 195-mediated catch-slip bondsProceedings of the National Academy of Sciences of the United States of America201356
Clinical trials in hepatocellular carcinoma: an updateLiver Cancer201354
Consensus recommendations and review by an International Expert Panel on Interventions in Hepatocellular Carcinoma (EPOIHCC)Liver International201352
Higher bone marrow LGALS3 expression is an independent unfavorable prognostic factor for overall survival in patients with acute myeloid leukemiaBlood201346
14-3-3ε overexpression contributes to epithelial-mesenchymal transition of hepatocellular carcinomaPLoS ONE201345
Bevacizumab with erlotinib as first-line therapy in Asian patients with advanced hepatocellular carcinoma: a multicenter phase II studyOncology201343
Inhibition of CIP2A determines erlotinib-induced apoptosis in hepatocellular carcinomaBiochemical Pharmacology201338
Sorafenib enhances radiation-induced apoptosis in hepatocellular carcinoma by inhibiting STAT3International Journal of Radiation Oncology Biology Physics201335
Oxidative stress enhances Axl-mediated cell migration through an Akt1/Rac1-dependent mechanismFree Radical Biology and Medicine201335
Development of in situ forming thermosensitive hydrogel for radiotherapy combined with chemotherapy in a mouse model of hepatocellular carcinomaMolecular Pharmaceutics201335
Detection of the Helicobacter pylori CagA protein in gastric mucosa-associated lymphoid tissue lymphoma cells: clinical and biological significanceBlood Cancer Journal201334
Inhibition of cell adhesion by a cadherin-11 antibody thwarts bone metastasisMolecular Cancer Research201333
Measurement of cerebral white matter perfusion using pseudocontinuous arterial spin labeling 3T magnetic resonance imaging--an experimental and theoretical investigation of feasibilityPLoS ONE201333
Multi-gene analyses from waste brushing specimens for patients with peripheral lung cancer receiving EBUS-assisted bronchoscopyLung Cancer201332